Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Whitman-Walker Institute is the research, education, and policy arm of Whitman-Walker Health, a community-based health system in Washington, D.C. The Institute specializes in clinical research and health policy focused on HIV/AIDS, sexual health, and LGBTQ+ health equity. It serves as a high-volume clinical trial site for both federal agencies like the NIH and major pharmaceutical partners, contributing to the development of breakthrough HIV prevention and treatment modalities. In addition to clinical trials, the Institute conducts behavioral and social science research to address health disparities in marginalized communities. Its work integrates clinical care with rigorous scientific inquiry to improve health outcomes and inform public policy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Whitman-Walker Institute.